Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Offen

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseM Vila, V Jackson-Lewis, S Vukosavic, et al.
Journal of Molecular Neuroscience : MN|April 17, 2001
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE)D Offen, J F Kaye, O Bernard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicingJ Sperling, J Chebath, H Arad-Dann, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's diseaseI Ziv, D Offen, R Haviv, et al.
Cell Biochemistry and Biophysics|April 5, 2007
Bax deficiency reduces infarct size and improves long-term function after myocardial infarctionE Hochhauser, Y Cheporko, N Yasovich, et al.
Cytotherapy|June 25, 2008
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's diseaseY S Levy, M Bahat-Stroomza, R Barzilay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 1998
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicityD Offen, P M Beart, N S Cheung, et al.
International Reviews of Immunology|January 1, 1990
Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic originsE Paul, A Manheimer-Lory, A Livneh, et al.
Experimental Neurology|January 31, 2012
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's diseaseO Sadan, N Shemesh, R Barzilay, et al.
Translational Psychiatry|July 27, 2012
Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in miceR Barzilay, T Ben-Zur, O Sadan, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseM Vila, V Jackson-Lewis, S Vukosavic, et al.
Journal of Molecular Neuroscience : MN|April 17, 2001
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE)D Offen, J F Kaye, O Bernard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicingJ Sperling, J Chebath, H Arad-Dann, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's diseaseI Ziv, D Offen, R Haviv, et al.
Cell Biochemistry and Biophysics|April 5, 2007
Bax deficiency reduces infarct size and improves long-term function after myocardial infarctionE Hochhauser, Y Cheporko, N Yasovich, et al.
Cytotherapy|June 25, 2008
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's diseaseY S Levy, M Bahat-Stroomza, R Barzilay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 1998
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicityD Offen, P M Beart, N S Cheung, et al.
International Reviews of Immunology|January 1, 1990
Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic originsE Paul, A Manheimer-Lory, A Livneh, et al.
Experimental Neurology|January 31, 2012
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's diseaseO Sadan, N Shemesh, R Barzilay, et al.
Translational Psychiatry|July 27, 2012
Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in miceR Barzilay, T Ben-Zur, O Sadan, et al.
Pageof 7